Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04239040
Title GVAX Plus Checkpoint Blockade in Neuroblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications
Therapies
Age Groups: child | senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Boston Children's Hospital Boston Massachusetts 02115 United States Details
Dana Farber Cancer Institite Boston Massachusetts 02115 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field